TrialClinical pharmacology and therapeutics2009

Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy.

J S McCune et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.